These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The interaction of cephaloridine with model membrane systems and rat kidney lysosomes. Fry M; Plummer DT Chem Biol Interact; 1979 Apr; 25(1):113-24. PubMed ID: 466724 [TBL] [Abstract][Full Text] [Related]
24. Prophylactic role of cephaloridine in surgical wounds. Suri PK; Johnston DW Can J Surg; 1975 Jul; 18(4):361-3. PubMed ID: 1148964 [TBL] [Abstract][Full Text] [Related]
25. Cephaloridine therapy as related to renal function. Kabins SA; Cohen S Antimicrob Agents Chemother (Bethesda); 1965; 5():922-32. PubMed ID: 5883518 [No Abstract] [Full Text] [Related]
27. Therapy with cephaloridine in renal impairment. Bechtol LD Curr Ther Res Clin Exp; 1972 Dec; 14(12):790-800. PubMed ID: 4629818 [No Abstract] [Full Text] [Related]
28. [Changes of blood urea nitrogen and serum creatinine levels following cephaloridine administration (author's transl)]. Hasumi M; Kashiwagi K; Amano M Jpn J Antibiot; 1981 Jul; 34(7):1106-12. PubMed ID: 7321190 [TBL] [Abstract][Full Text] [Related]
29. Cephalothin and cephaloridine: comparative pharmacodynamics in chronic uremia. Perkins RL; Smith EJ; Saslaw S Am J Med Sci; 1969 Feb; 257(2):116-24. PubMed ID: 4974464 [No Abstract] [Full Text] [Related]
30. Effect of cephaloridine on the rat kidney lysosomal membrane integrity in vivo and in vitro [proceedings]. Ngaha EO West Afr J Pharmacol Drug Res; 1977 Jun; 4(1):59P-60P. PubMed ID: 602188 [No Abstract] [Full Text] [Related]
31. [Clinical trials with cephaloridine (Ceporin)]. Rohner R; Gubler R; Wyss F Schweiz Med Wochenschr; 1967 Nov; 97(45):1506-12. PubMed ID: 4875894 [No Abstract] [Full Text] [Related]
33. [Nil nocere. On the problem of the nephrotoxicity of cephaloridine]. Straube W; König K Munch Med Wochenschr; 1969 Mar; 111(12):665-9. PubMed ID: 5819271 [No Abstract] [Full Text] [Related]
34. Renal function during cefuroxime treatment in patients with pre-existing renal impairment. Trollfors B; Suurkula M; Price JD; Norrby R J Antimicrob Chemother; 1980 Sep; 6(5):665-70. PubMed ID: 6773920 [No Abstract] [Full Text] [Related]
35. Cephaloridine. II. The effect of cephaloridine on experimental model infections. Hejzlar M; Výmola F; Paroubek M; Bdinkova H; Majorová J; Hájková L; Janovská D J Hyg Epidemiol Microbiol Immunol; 1967; 11(4):459-68. PubMed ID: 5629908 [No Abstract] [Full Text] [Related]
36. Cephaloridine in the treatment of urinary proteus infections. Gardner JC; Price TM; Southwell N Lancet; 1966 Oct; 2(7466):725-7. PubMed ID: 4162058 [No Abstract] [Full Text] [Related]
37. Evaluation on cephaloridine in the treatment of purulent meningitis in children. Lembong CM; Djamin J; Kristanti L Paediatr Indones; 1972 Sep; 12(9):377-84. PubMed ID: 4679475 [No Abstract] [Full Text] [Related]
38. [Effectiveness of cephalosporins in experimental anaerobic gas infection]. Poliak MS Antibiotiki; 1974 Aug; 19(8):733-6. PubMed ID: 4375943 [No Abstract] [Full Text] [Related]
39. Treatment of gonorrhoea with penicillin, cephaloridine, and doxycycline. Söltz-Szöts J; Kokoschka H Br J Vener Dis; 1973 Apr; 49(2):177-80. PubMed ID: 4704868 [No Abstract] [Full Text] [Related]
40. Clinical and laboratory experiences with cephaloridine. Stratford BC; Dixson SH Postgrad Med J; 1967 Aug; 43():Suppl 43:158+. PubMed ID: 5183153 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]